Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Maternal smoking as an independent risk factor for the development of severe retinopathy of prematurity in very preterm infants

Abstract

Background/objectives

Retinopathy of prematurity (ROP) is a severe neonatal complication potentially leading to visual impairment and blindness. Known risk factors include preterm birth, low birth weight and respiratory support. Limited and contradictory data exist on the risk of maternal smoking during pregnancy on the development of ROP. This study aims to investigate smoking as an independent risk factor for the development of severe ROP (≥stage 3).

Subjects/methods

This is a single centre retrospective case-control study of prospectively collected clinical data of infants born before 32 weeks of gestation between 2001 and 2012 at a tertiary care university hospital. The association between maternal smoking during pregnancy and the development of severe ROP was analyzed by multivariate logistic regression.

Results

In total, n = 751 infants born < 32 weeks of gestation were included in this study. In total, 52.9% (n = 397) were diagnosed with ROP and 10.8% (n = 81) developed ROP ≥ stage 3. In total, 8.4% (n = 63) mothers presented with a history of smoking during pregnancy, which was associated to a higher rate of ROP (OR 2.59, 95% CI 1.10–6.12). Low gestational age, low birth weight and prolonged respiratory support were confirmed as independent risk factors for the development of severe ROP.

Conclusions

To date, this is the largest study evaluating the effect of maternal smoking on the development of ROP. Maternal smoking during pregnancy is identified as an independent risk factor for the development of severe ROP in preterm infants born < 32 weeks of gestation.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Vogel JP, Chawanpaiboon S, Moller A-B, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52:3–12.

    Article  Google Scholar 

  2. 2.

    Chawanpaiboon S, Vogel JP, Moller A-B, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7:e37–e46.

    Article  Google Scholar 

  3. 3.

    Natarajan G, Shankaran S, Nolen TL, Sridhar A, Kennedy KA, Hintz SR, et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics. 2019;144:e20183537.

    Article  Google Scholar 

  4. 4.

    Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017;102:853–7.

    Article  Google Scholar 

  5. 5.

    Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–37.

    Article  Google Scholar 

  6. 6.

    Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1(S1)):35–49.

    Article  Google Scholar 

  7. 7.

    Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993;100:230–7.

    CAS  Article  Google Scholar 

  8. 8.

    Kanungo J, James A, McMillan D, Lodha A, Faucher D, Lee SK, et al. Advanced maternal age and the outcomes of preterm neonates: a social paradox? Obstet Gynecol. 2011;118:872–7.

    Article  Google Scholar 

  9. 9.

    Uchida A, Miwa M, Shinoda H, Koto T, Nagai N, Mochimaru H, et al. Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. J Ophthalmol. 2014;2014:187929–5.

    Article  Google Scholar 

  10. 10.

    Wu W-C, Ong FS-C, Kuo JZ-C, Lai C-C, Wang N-C, Chen K-J, et al. Retinopathy of prematurity and maternal age. Retina. 2010;30:327–31.

    CAS  Article  Google Scholar 

  11. 11.

    Abdel HA, Mohamed GB, Othman MF. Retinopathy of prematurity: a study of incidence and risk factors in NICU of Al-Minya University Hospital in Egypt. J Clin Neonatol. 2012;1:76–81.

    Article  Google Scholar 

  12. 12.

    Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics. 2005;115:990–6.

    Article  Google Scholar 

  13. 13.

    Figueras-Aloy J, Alvarez-Domínguez E, Morales-Ballus M, Salvia-Roiges MD, Moretones-Suñol G. [Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity?]. Pediatrics. 2010;73:327–33.

    CAS  Google Scholar 

  14. 14.

    Wikstrand MH, Hård A-L, Niklasson A, Smith L, Löfqvist C, Hellström A. Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity. Acta Paediatr. 2011;100:1528–33.

    Article  Google Scholar 

  15. 15.

    Hirabayashi H, Honda S, Morioka I, Yokoyama N, Sugiyama D, Nishimura K, et al. Inhibitory effects of maternal smoking on the development of severe retinopathy of prematurity. Eye. 2010;24:1024–7.

    CAS  Article  Google Scholar 

  16. 16.

    Yusuf K, Alshaikh B, da Silva O, Lodha AK, Wilson RD, Alvaro RE, et al. Neonatal outcomes of extremely preterm infants exposed to maternal hypertension and cigarette smoking. J Perinatol. 2018;38:1051–9.

    Article  Google Scholar 

  17. 17.

    Spiegler J, Jensen R, Segerer H, Ehlers S, Kühn T, Jenke A, et al. Influence of smoking and alcohol during pregnancy on outcome of VLBW infants. Z Geburtshilfe Neonatol. 2013;217:215–9.

    CAS  Article  Google Scholar 

  18. 18.

    Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011;17:589–604.

    CAS  Article  Google Scholar 

  19. 19.

    Isayama T, Shah PS, Ye XY, Dunn M, da Silva O, Alvaro R, et al. Adverse impact of maternal cigarette smoking on preterm infants: a population-based cohort study. Am J Perinatol. 2015;32:1105–11.

    Article  Google Scholar 

  20. 20.

    Hayashi K, Matsuda Y, Kawamichi Y, Shiozaki A, Saito S. Smoking during pregnancy increases risks of various obstetric complications: a case-cohort study of the Japan Perinatal Registry Network database. J Epidemiol. 2011;21:61–66.

    Article  Google Scholar 

  21. 21.

    Ion R, Bernal AL. Smoking and preterm birth. Reprod Sci. 2015;22:918–26.

    CAS  Article  Google Scholar 

  22. 22.

    Caleyachetty R, Tait CA, Kengne AP, Corvalan C, Uauy R, Echouffo-Tcheugui JB. Tobacco use in pregnant women: analysis of data from Demographic and Health Surveys from 54 low-income and middle-income countries. Lancet Glob Health. 2014;2:e513–e520.

    Article  Google Scholar 

  23. 23.

    Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012;367:2515–26.

    CAS  Article  Google Scholar 

  24. 24.

    Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92:10457–61.

    CAS  Article  Google Scholar 

  25. 25.

    Pons M, Marin-Castaño ME. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Investig Ophthalmol Vis Sci. 2011;52:3842–53.

    CAS  Article  Google Scholar 

  26. 26.

    Zhang Y, Ma A, Wang L, Zhao B. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio. Ophthalmic Res. 2015;55:1–9.

    CAS  Article  Google Scholar 

  27. 27.

    International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991–9.

    Article  Google Scholar 

  28. 28.

    Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93:F351–61.

    CAS  Article  Google Scholar 

  29. 29.

    Wagijo M-A, Sheikh A, Duijts L, Been JV. Reducing tobacco smoking and smoke exposure to prevent preterm birth and its complications. Paediatr Respir Rev. 2017;22:3–10.

    PubMed  Google Scholar 

  30. 30.

    Miyazaki Y, Hayashi K, Imazeki S. Smoking cessation in pregnancy: psychosocial interventions and patient-focused perspectives. Int J Women’s Health. 2015;7:415–27.

    Article  Google Scholar 

  31. 31.

    Bakker R, Kruithof C, Steegers EAP, Tiemeier H, Mackenbach JP, Hofman A, et al. Assessment of maternal smoking status during pregnancy and the associations with neonatal outcomes. Nicotine Tob Res. 2011;13:1250–6.

    Article  Google Scholar 

  32. 32.

    Dammann O. Inflammation and retinopathy of prematurity. Acta Paediatr. 2010;99:975–7.

    Article  Google Scholar 

  33. 33.

    Kuon RJ, Hudalla H, Seitz C, Hertler S, Gawlik S, Fluhr H, et al. Impaired neonatal outcome after emergency cerclage adds controversy to prolongation of pregnancy. PLoS ONE. 2015;10:e0129104.

  34. 34.

    Evereklioglu C, Ozkiriş A, Alaşehirli B, Sari I, Güldür E, Cengiz B, et al. Effect of gestational nicotine treatment on newborn rat retina: a histopathological and morphometric analysis. Ophthalmic Physiol Opt. 2003;23:527–33.

    Article  Google Scholar 

  35. 35.

    Ram FSF, McDonald EM. Response to ‘Inhibitory effects of maternal smoking on the development of severe retinopathy of prematurity’. Eye. 2011;25:123–4.

    CAS  Article  Google Scholar 

  36. 36.

    Chiang MF, Jiang L, Gelman R, Du YE, Flynn JT. Interexpert agreement of plus disease diagnosis in retinopathy of prematurity. Arch Ophthalmol. 2007;125:875–80.

    Article  Google Scholar 

  37. 37.

    Campbell JP, Ryan MC, Lore E, Tian P, Ostmo S, Jonas K, et al. Diagnostic discrepancies in retinopathy of prematurity classification. Ophthalmology. 2016;123:1795–801.

    Article  Google Scholar 

  38. 38.

    Lundgren P, Kistner A, Andersson EM, Hansen Pupp I, Holmström G, Ley D, et al. Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age. PLoS ONE. 2014;9:e109460.

  39. 39.

    Razak A, Faden M. Association of small for gestational age with retinopathy of prematurity: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105:270–8.

    Article  Google Scholar 

  40. 40.

    Slidsborg C, Jensen A, Forman JL, Rasmussen S, Bangsgaard R, Fledelius HC, et al. Neonatal risk factors for treatment-demanding retinopathy of prematurity: a danish national study. Ophthalmology. 2016;123:796–803.

    Article  Google Scholar 

  41. 41.

    York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol. 2004;24:82–87.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Contributions

HH: protocol/project development, data collection or management, data analysis, paper writing/editing. TB: data collection or management, data analysis. JP: paper editing. TS: paper editing. RJK: protocol/project development, data collection or management, data analysis, paper writing/editing. All authors read and approved the final paper.

Corresponding author

Correspondence to Ruben-J. Kuon.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the Heidelberg University institutional review board (IRB, S-094/2013). All procedures performed in the study were in accordance with the ethical standards and data safety of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

The institutional ethics committee waived informed consent due to the retrospective nature of the study, and pseudonymization of data

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hudalla, H., Bruckner, T., Pöschl, J. et al. Maternal smoking as an independent risk factor for the development of severe retinopathy of prematurity in very preterm infants. Eye 35, 799–804 (2021). https://doi.org/10.1038/s41433-020-0963-4

Download citation

Further reading

Search

Quick links